ArticleFrontiers in immunology2025

Toll-like receptor 3 activation enhances antitumor immune response in lung adenocarcinoma through NF-κB signaling pathway.

Ang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.